Year Ended December 31, 2021 2020 Revenue Software-as-a-service related $ 60,402 $ 72,198 Maintenance 1,717 677 Professional services 507 86 Total software-related revenue 62,626 72,961 Other 23 211 Total net revenue 62,649 73,172 Cost of Revenue Software-as-a-service related 21,503 23,056 Maintenance 1,174 361 Professional services 14 16 Amortization of developed technologies 4,988 4,755 Total software-related cost of revenue 27,679 28,188 Other 128 1,038 Total cost of revenue 27,807 29,226 Gross Profit 34,842 43,946 Operating Expenses Selling, general and administrative 52,092 48,534 Research and development 19,707 17,274 Amortization of acquisition-related assets 3,942 3,676 Impairment of intangible assets, including internal-use software — 729 Total operating expenses 75,741 70,213 Loss from operations (40,899) (26,267) Interest expense, net (14,481) (19,199) Other expense, net (3,089) (10,824) Loss from related party equity method investment — (31,702) Loss from continuing operations before income taxes (58,469) (87,992) Provision for income taxes 97 447 Net loss from continuing operations (58,566) (88,439) Income from discontinued operations, net of tax, attributable to NantHealth 23 31,993 Net loss (58,543) (56,446) Net loss attributable to noncontrolling interests (284) (120) Net loss attributable to NantHealth $ (58,259) $ (56,326) Basic and diluted net loss per share attributable to NantHealth: Continuing operations - common stock $ (0.51) $ (0.80) Discontinued operations - common stock $ — $ 0.29 Total net loss per share - common stock $ (0.51) $ (0.51) Weighted average shares outstanding Basic and diluted - common stock 114,148,604 110,954,858 The accompanying notes are an integral part of these Consolidated Financial Statements. NantHealth, Inc. Consolidated Statements of Operations (Dollars in thousands, except per share amounts) - 97 -
RkJQdWJsaXNoZXIy NTIzOTM0